RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

Core Insights - Recordati, a global pharmaceutical company, has announced the appointment of Mike McClellan as the new Chief Financial Officer (CFO) effective January 1, 2026 [1][3] - McClellan brings nearly 30 years of experience in the pharmaceutical industry, having previously served as CFO at Almirall and held significant roles at Teva and Sanofi [2][3] - The CEO of Recordati expressed confidence in McClellan's expertise to drive the company's strategy of consistent growth and stakeholder engagement [3] Company Overview - Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with operations in approximately 150 countries and over 4,500 employees [4] - The company focuses on providing treatments across specialty and primary care, as well as rare diseases, with a mission to empower individuals to live life to the fullest [4]